drugset / Trial / NCT00396656
Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
RandomizedCrossoverOpen-labelTreatment
Summary
This study evaluated the effect of valsartan on small vessel blood flow in patients with mild-to-moderate hypertension in direct comparison to atenolol and hydrochlorothiazide.
Timeline
- Start
- 2005-12
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atenolol | Other / unclassified | 100 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | Oral |
| Subject | Valsartan | Small molecule | 320 mg | Oral |